vs
Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and Snail, Inc. (SNAL). Click either name above to swap in a different company.
Snail, Inc. is the larger business by last-quarter revenue ($25.1M vs $13.8M, roughly 1.8× FENNEC PHARMACEUTICALS INC.). Snail, Inc. runs the higher net margin — -3.4% vs -34.7%, a 31.3% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs -4.2%). Over the past eight quarters, Snail, Inc.'s revenue compounded faster (33.4% CAGR vs -26.3%).
Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.
Suzhou Snail Digital Technology Co., Ltd., doing business as Snail, is a Chinese video game company and a Virtual Network Operator headquartered in Suzhou, China, which has branches Snail Games and Snail Mobile. Its division, Snail USA, markets Snail Games products in North America, South America, & Europe. Snail Games products include massively multiplayer online (MMOs), real-time strategy (RTS), and casual games. Its global registered user base has reached over 70 million accounts. The U.S....
FENC vs SNAL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $25.1M |
| Net Profit | $-4.8M | $-862.2K |
| Gross Margin | — | 38.3% |
| Operating Margin | -18.5% | -6.0% |
| Net Margin | -34.7% | -3.4% |
| Revenue YoY | 73.8% | -4.2% |
| Net Profit YoY | -141.1% | -177.0% |
| EPS (diluted) | $-0.17 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $25.1M | ||
| Q3 25 | $12.5M | $13.8M | ||
| Q2 25 | $9.7M | $22.2M | ||
| Q1 25 | $8.8M | $20.1M | ||
| Q4 24 | $7.9M | $26.2M | ||
| Q3 24 | $7.0M | $22.5M | ||
| Q2 24 | $7.3M | $21.6M | ||
| Q1 24 | $25.4M | $14.1M |
| Q4 25 | $-4.8M | $-862.2K | ||
| Q3 25 | $-638.0K | $-7.9M | ||
| Q2 25 | $-3.2M | $-16.6M | ||
| Q1 25 | $-1.2M | $-1.9M | ||
| Q4 24 | $-2.0M | $1.1M | ||
| Q3 24 | $-5.7M | $235.1K | ||
| Q2 24 | $-5.6M | $2.3M | ||
| Q1 24 | $12.8M | $-1.8M |
| Q4 25 | — | 38.3% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 31.3% | ||
| Q1 25 | — | 29.1% | ||
| Q4 24 | — | 43.3% | ||
| Q3 24 | — | 38.6% | ||
| Q2 24 | — | 37.5% | ||
| Q1 24 | — | 14.7% |
| Q4 25 | -18.5% | -6.0% | ||
| Q3 25 | -1.5% | -71.3% | ||
| Q2 25 | -28.3% | -8.2% | ||
| Q1 25 | -9.2% | -20.4% | ||
| Q4 24 | -11.8% | 11.5% | ||
| Q3 24 | -74.6% | 1.8% | ||
| Q2 24 | -69.4% | 12.4% | ||
| Q1 24 | 54.2% | -15.6% |
| Q4 25 | -34.7% | -3.4% | ||
| Q3 25 | -5.1% | -56.9% | ||
| Q2 25 | -32.7% | -74.7% | ||
| Q1 25 | -13.3% | -9.7% | ||
| Q4 24 | -25.0% | 4.3% | ||
| Q3 24 | -82.2% | 1.0% | ||
| Q2 24 | -76.5% | 10.4% | ||
| Q1 24 | 50.6% | -12.6% |
| Q4 25 | $-0.17 | — | ||
| Q3 25 | $-0.02 | — | ||
| Q2 25 | $-0.11 | $-0.44 | ||
| Q1 25 | $-0.04 | $-0.06 | ||
| Q4 24 | $-0.02 | $0.03 | ||
| Q3 24 | $-0.21 | $0.01 | ||
| Q2 24 | $-0.20 | $0.06 | ||
| Q1 24 | $0.41 | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $36.8M | $8.6M |
| Total DebtLower is stronger | — | $14.6M |
| Stockholders' EquityBook value | $35.5M | $-16.4M |
| Total Assets | $70.6M | $59.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $36.8M | $8.6M | ||
| Q3 25 | $21.9M | $12.3M | ||
| Q2 25 | $18.7M | $7.9M | ||
| Q1 25 | $22.7M | $9.4M | ||
| Q4 24 | $26.6M | $7.3M | ||
| Q3 24 | $40.3M | $10.6M | ||
| Q2 24 | $43.1M | $15.5M | ||
| Q1 24 | $51.2M | $16.1M |
| Q4 25 | — | $14.6M | ||
| Q3 25 | $19.4M | $10.5M | ||
| Q2 25 | $19.4M | $11.8M | ||
| Q1 25 | $19.4M | $9.0M | ||
| Q4 24 | $19.3M | $5.7M | ||
| Q3 24 | $32.1M | $5.7M | ||
| Q2 24 | $31.8M | $5.8M | ||
| Q1 24 | $31.3M | $6.5M |
| Q4 25 | $35.5M | $-16.4M | ||
| Q3 25 | $-4.5M | $-15.6M | ||
| Q2 25 | $-7.5M | $-8.0M | ||
| Q1 25 | $-5.9M | $9.1M | ||
| Q4 24 | $-5.9M | $9.7M | ||
| Q3 24 | $-5.2M | $8.2M | ||
| Q2 24 | $-1.4M | $7.9M | ||
| Q1 24 | $3.0M | $5.6M |
| Q4 25 | $70.6M | $59.3M | ||
| Q3 25 | $49.3M | $51.1M | ||
| Q2 25 | $44.9M | $58.0M | ||
| Q1 25 | $46.4M | $64.5M | ||
| Q4 24 | $44.9M | $62.2M | ||
| Q3 24 | $58.9M | $66.8M | ||
| Q2 24 | $63.2M | $75.4M | ||
| Q1 24 | $69.2M | $78.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.99× | ||
| Q4 24 | — | 0.59× | ||
| Q3 24 | — | 0.70× | ||
| Q2 24 | — | 0.73× | ||
| Q1 24 | 10.40× | 1.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.0M | $-5.3M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.0M | $-5.3M | ||
| Q3 25 | $1.5M | $6.6M | ||
| Q2 25 | $-3.7M | $-3.2M | ||
| Q1 25 | $-4.3M | $764.5K | ||
| Q4 24 | $-1.5M | $-3.6M | ||
| Q3 24 | $-2.2M | $-5.0M | ||
| Q2 24 | $-8.4M | $206.6K | ||
| Q1 24 | $39.0M | $6.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -3.21× | ||
| Q3 24 | — | -21.05× | ||
| Q2 24 | — | 0.09× | ||
| Q1 24 | 3.04× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FENC
Segment breakdown not available.
SNAL
| Pc | $14.7M | 59% |
| Platform Three | $5.2M | 21% |
| Platform Two | $3.3M | 13% |
| Sales Channel Directly To Consumer Mobile Sale | $1.6M | 6% |
